Nikki Chang
Pharmacist · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nikki Chang’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A66004 · Cancelled
Licence status: Cancelled · since 1998 · University of Texas Southwestern Medical School at Dallas.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$88,934
Pharmacies billed $88,934 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 407) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
189 generic and 180 brand-name prescriptions · $88,934 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 79 | $58,616 | $742 |
| Jardiance | 15 | $7,826 | $522 |
| Humulin N Kwikpen | 25 | $3,941 | $158 |
| Humalog Kwikpen U-100 | 14 | $3,636 | $260 |
| Insulin Glargine-Yfgn | 11 | $1,533 | $139 |
See all 10 drugs
| Ozempic | 79 | $58,616 | $742 |
| Jardiance | 15 | $7,826 | $522 |
| Humulin N Kwikpen | 25 | $3,941 | $158 |
| Humalog Kwikpen U-100 | 14 | $3,636 | $260 |
| Insulin Glargine-Yfgn | 11 | $1,533 | $139 |
| Atorvastatin | 52 | $624 | $12 |
| Metformin Hcl Er | 59 | $555 | $9 |
| Ultra-Fine Mini Pen Needle | 16 | $553 | $35 |
| Glipizide | 38 | $537 | $14 |
| Metformin | 24 | $298 | $12 |
Year by year
| 2024 | 407 | 64 | 0% (0) | 44% | $88,934 |
| 2023 | 470 | 107 | 0% (0) | 38% | $103,738 |
| 2022 | 681 | 147 | 0% (0) | 31% | $63,115 |
| 2021 | 691 | 134 | 0% (0) | 33% | $76,758 |
| 2020 | 632 | 135 | 0% (0) | 32% | $74,091 |
| 2019 | 767 | 154 | 0% (0) | 36% | $84,773 |
| 2018 | 741 | 141 | 0% (0) | 42% | $75,791 |
| 2017 | 643 | 142 | 0% (0) | 46% | $59,829 |
| 2016 | 691 | 148 | 0% (0) | 50% | $55,934 |
| 2015 | 344 | 100 | 0% (0) | 48% | $35,115 |
| 2014 | 219 | 58 | 0% (0) | 53% | $24,484 |
| 2013 | 208 | 49 | 0% (0) | 47% | $20,247 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Ozempic | 58 | $55,108 | $950 |
| Jardiance | 13 | $11,670 | $898 |
| Humulin N | 22 | $6,207 | $282 |
| Humulin N Kwikpen | 31 | $5,306 | $171 |
| Humulin R | 20 | $3,961 | $198 |
| Glipizide | 57 | $766 | $13 |
| Metformin | 48 | $611 | $13 |
| Atorvastatin | 46 | $609 | $13 |
| Veo Insulin | 19 | $609 | $32 |
| Metformin Hcl Er | 50 | $484 | $10 |
| Veo Insulin | 16 | $352 | $22 |
2022: 13 drugs
| Humulin N | 89 | $18,540 | $208 |
| Jardiance | 11 | $9,062 | $824 |
| Lantus | 19 | $8,378 | $441 |
| Humulin R | 48 | $6,265 | $131 |
| Humulin N Kwikpen | 17 | $3,988 | $235 |
| Glipizide | 98 | $1,343 | $14 |
| Atorvastatin | 81 | $1,215 | $15 |
| Veo Insulin | 49 | $1,094 | $22 |
| Metformin Hcl Er | 72 | $682 | $9 |
| Veo Insulin | 25 | $653 | $26 |
| Metformin | 54 | $633 | $12 |
| Veo Insulin | 23 | $480 | $21 |
| Simvastatin | 22 | $277 | $13 |
2021: 14 drugs
| Humulin N | 118 | $22,788 | $193 |
| Lantus | 13 | $10,030 | $772 |
| Humulin R | 49 | $6,647 | $136 |
| Humulin 70/30 Kwikpen | 13 | $5,883 | $453 |
| Humulin 70-30 | 11 | $3,140 | $285 |
| Glipizide | 101 | $1,336 | $13 |
| Veo Insulin | 63 | $1,267 | $20 |
| Atorvastatin | 63 | $909 | $14 |
| Metformin | 69 | $846 | $12 |
| Veo Insulin | 31 | $743 | $24 |
| Veo Insulin | 25 | $480 | $19 |
| Ultra-Fine Nano Pen Needle | 12 | $431 | $36 |
| Metformin Hcl Er | 45 | $415 | $9 |
| Simvastatin | 17 | $225 | $13 |
2020: 14 drugs
| Humulin N | 104 | $22,870 | $220 |
| Humulin R | 44 | $7,778 | $177 |
| Humulin N Kwikpen | 12 | $3,859 | $322 |
| Humulin 70/30 Kwikpen | 11 | $2,746 | $250 |
| Glipizide | 90 | $1,280 | $14 |
| Veo Insulin | 69 | $1,121 | $16 |
| Atorvastatin | 63 | $1,012 | $16 |
| Metformin | 54 | $679 | $13 |
| Ultra-Fine Nano Pen Needle | 14 | $459 | $33 |
| Veo Insulin | 22 | $412 | $19 |
| Veo Insulin | 23 | $403 | $18 |
| Metformin Hcl Er | 32 | $315 | $10 |
| Simvastatin | 18 | $210 | $12 |
| Lisinopril | 15 | $178 | $12 |
2019: 14 drugs
| Humulin N | 148 | $29,513 | $199 |
| Humulin R | 63 | $10,596 | $168 |
| Humulin 70-30 | 18 | $5,785 | $321 |
| Humulin N Kwikpen | 15 | $4,107 | $274 |
| Atorvastatin | 72 | $1,719 | $24 |
| Glipizide | 117 | $1,586 | $14 |
| Veo Insulin | 59 | $1,031 | $17 |
| Metformin | 74 | $964 | $13 |
| Veo Insulin | 41 | $699 | $17 |
| Ultra-Fine Nano Pen Needle | 14 | $443 | $32 |
| Veo Insulin | 21 | $421 | $20 |
| Metformin Hcl Er | 37 | $358 | $10 |
| Simvastatin | 18 | $210 | $12 |
| Lisinopril | 16 | $190 | $12 |
2018: 13 drugs
| Humulin N | 146 | $27,134 | $186 |
| Humulin R | 63 | $11,074 | $176 |
| Humulin 70-30 | 14 | $4,921 | $351 |
| Glipizide | 124 | $2,035 | $16 |
| Humulin N Kwikpen | 12 | $1,419 | $118 |
| Atorvastatin | 48 | $1,351 | $28 |
| Metformin | 77 | $1,018 | $13 |
| Veo Insulin | 59 | $959 | $16 |
| Veo Insulin | 41 | $728 | $18 |
| Veo Insulin | 28 | $625 | $22 |
| Metformin Hcl Er | 34 | $467 | $14 |
| Simvastatin | 22 | $261 | $12 |
| Lisinopril | 11 | $142 | $13 |
2017: 13 drugs
| Humulin N | 138 | $23,250 | $168 |
| Humulin R | 77 | $11,254 | $146 |
| Humulin 70-30 | 26 | $6,600 | $254 |
| Glipizide | 90 | $1,594 | $18 |
| Insulin | 46 | $1,018 | $22 |
| Insulin | 51 | $986 | $19 |
| Atorvastatin | 32 | $984 | $31 |
| Metformin | 63 | $803 | $13 |
| Insulin | 24 | $723 | $30 |
| Metformin Hcl Er | 19 | $268 | $14 |
| Losartan | 12 | $253 | $21 |
| Lisinopril | 14 | $183 | $13 |
| Simvastatin | 13 | $172 | $13 |
2016: 11 drugs
| Humulin N | 164 | $21,333 | $130 |
| Humulin R | 104 | $12,944 | $124 |
| Humulin 70-30 | 29 | $5,648 | $195 |
| Insulin | 67 | $1,718 | $26 |
| Glipizide | 74 | $1,342 | $18 |
| Insulin | 35 | $1,047 | $30 |
| Insulin | 47 | $914 | $19 |
| Atorvastatin | 25 | $802 | $32 |
| Metformin | 64 | $778 | $12 |
| Metformin Hcl Er | 21 | $315 | $15 |
| Simvastatin | 11 | $229 | $21 |
2015: 9 drugs
| Humulin N | 68 | $9,439 | $139 |
| Humulin R | 44 | $5,287 | $120 |
| Humulin 70-30 | 17 | $3,015 | $177 |
| Insulin | 24 | $1,639 | $68 |
| Insulin | 19 | $855 | $45 |
| Insulin | 20 | $749 | $37 |
| Metformin | 46 | $616 | $13 |
| Glipizide | 27 | $473 | $18 |
| Atorvastatin | 14 | $446 | $32 |
2014: 8 drugs
| Humulin R | 22 | $7,936 | $361 |
| Humulin N | 41 | $4,849 | $118 |
| Humulin 70-30 | 11 | $954 | $87 |
| Insulin | 13 | $696 | $54 |
| Insulin | 11 | $695 | $63 |
| Atorvastatin | 17 | $684 | $40 |
| Metformin | 32 | $403 | $13 |
| Glipizide | 11 | $175 | $16 |
2013: 9 drugs
| Lantus | 15 | $8,627 | $575 |
| Humulin 70-30 | 17 | $2,231 | $131 |
| Humulin N | 19 | $1,800 | $95 |
| Humalog | 12 | $1,636 | $136 |
| Humulin R | 14 | $893 | $64 |
| Insulin | 14 | $794 | $57 |
| Atorvastatin | 18 | $637 | $35 |
| Metformin | 27 | $331 | $12 |
| Glipizide | 16 | $260 | $16 |
Professional record
- NPI
- 1144590456
- Licence
- CA 66004California A66004: Cancelled
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- 700 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2012-01-03
- NPI last updated
- 2021-11-23
- NPI record certified
- 2021-11-23
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.